Pharmaceutical Preparations · CIK 1677940
BeyondSpring Inc. develops and commercializes novel cancer therapies using its Targeted Protein Degradation (TPD) platform
Comparable business profile · signals at a glance
In the 90 days to Oct 17, 2025: 4 sold $561K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 17, 2025 | Decheng Capital China Life Sciences Usd Fund Ii, L.P.TenPercentOwner | Sell | 45,513 | $1.76 | $80K |
| Oct 16, 2025 | Decheng Capital China Life Sciences Usd Fund Ii, L.P.TenPercentOwner | Sell | 85,798 | $1.72 | $148K |
| Oct 15, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 17,960 | $1.65 | $30K |
| Oct 14, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 28,495 | $1.65 | $47K |
| Oct 13, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 107,361 | $1.70 | $183K |
| Oct 10, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 2,390 | $1.77 | $4K |
| Oct 9, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 3,979 | $1.81 | $7K |
| Oct 8, 2025 | Decheng Capital Global Healthcare Gp, LlcTenPercentOwner | Sell | 7,507 | $1.77 | $13K |
| Oct 7, 2025 | Decheng Capital Management Iii (Cayman), LlcTenPercentOwner | Sell | 2,100 | $1.79 | $4K |
| Oct 6, 2025 | Decheng Capital Management Iii (Cayman), LlcTenPercentOwner | Sell | 17,500 | $1.78 | $31K |
| Oct 3, 2025 | Decheng Capital Management Iii (Cayman), LlcTenPercentOwner | Sell | 600 | $1.76 | $1K |
| Oct 2, 2025 | Cui XiangminTenPercentOwner | Sell | 600 | $1.73 | $1K |
| Oct 1, 2025 | Cui XiangminTenPercentOwner | Sell | 2,601 | $1.80 | $5K |
| Sep 30, 2025 | Cui XiangminTenPercentOwner | Sell | 4,464 | $1.81 | $8K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.